Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: A randomized controlled multicentre study

Human Reproduction

Volumn 28, Issue 10, 2013, Pages 2804-2812

  Konig T E ^a   Van Der Houwen, L E E ^a   Overbeek, A ^a   Hendriks, M L ^a   Beutler Beemsterboer, S N ^a   Kuchenbecker, W K H ^b   Renckens, C N M ^c   Bernardus, R E ^d   Schats, R ^a   Homburg, R ^a   Hompes, P G A ^a   Lambalk, C B ^a,e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ISALA HOSPITAL   (Netherlands)

^c Division of Reproductive Medicine   (Netherlands)

^d Division of Internal Medicine   (Netherlands)

^e GHENT UNIVERSITY   (Belgium)

Author keywords

assisted reproduction technology; GnRH antagonist; LH; ovarian stimulation; pregnancy rates

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADD ON THERAPY; ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HORMONE RESPONSE; HOSPITAL PATIENT; HUMAN; INTENTION TO TREAT ANALYSIS; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; MULTICENTER STUDY; NIDATION; OVARY HYPERSTIMULATION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL;

ASSISTED REPRODUCTION TECHNOLOGY; GNRH ANTAGONIST; LH; OVARIAN STIMULATION; PREGNANCY RATES;

ADULT; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; LOGISTIC MODELS; LUTEINIZING HORMONE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE;

EID: 84885120862     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det266     Document Type: Article

References (23)

1. Albano C, Smitz J, Camus M, Riethmuüller-Winzen H, Van Steirteghem A, Devroey P. Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 1997;67:917-922.
2. Barrenetxea G, Agirregoikoa JA, Jimeenez MR, de Larruzea AL, Ganzabal T, Carbonero K. Ovarian response and pregnancy outcome in poor responder women: A randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril 2008;89:546-553.
3. Baruffi RL, Mauri AL, Petersen CG, Felipe V, Martins AM, Cornicelli J, Cavagna M, Oliveira JB, Franco JG Jr. Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: A meta-analysis. Reprod Biomed Online 2007; 14:14-25.
4. Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Pellicer A. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: An age-adjusted analysis. Fertil Steril 2011; 95:1031-1036.
5. Cédrin-Durnerin I, Grange-Dujardin D, Laffy A, Parneix I, Massin N, Galey J, Théron L, Wolf JP, ConordC, Clément P, Jayot S, Hugues JN. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: A prospective randomized study. Hum Reprod 2004; 19:1979-1984.
6. Fábregues F, Creus M, Penärrubia J, Manau D, Vanrell JA, Balasch J. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age. Fertil Steril 2006;85:925-931.
7. Fábregues F, Iraola A, Casals G, Creus M, Carmona F, Balasch J. Evaluation of two doses of recombinant human luteinizing hormone supplementation in down-regulated women of advanced reproductive age undergoing follicular stimulation for IVF: A randomized clinical study. Eur J Obstet Gynecol Reprod Biol 2011;158:56-61.
8. Ferraretti AP, Gianaroli L, Magli MC, D'angelo A, Farfalli V, Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 2004; 82:1521-1526.
9. Fleming R, Jenkins J. The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles. Reprod Biomed Online 2010;21:446-449.
10. Fleming R, Lloyd F, Herbert M, Fenwick J, Griffiths T, Murdoch A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 1998; 13:1788-1792.
11. Fujimoto VY, Monroe SE, Nelson LR, Downey D, Jaffe RB. Dose-related suppression of serum luteinizing hormone in women by a potent new gonadotropin-releasing hormone antagonist (Ganirelix) administered by intranasal spray. Fertil Steril 1997;67:469-473.
12. Griesinger G, Schultze-Mosgau A, Dafopoulos K, Schroeder A, Schroer A, von Otte S, Hornung D, Diedrich K, Felberbaum R. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Hum Reprod 2005;20:1200-1206.
13. Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 2001;179:39-46. Review.
14. Humaidan P, Bungum M, Bungum L, Yding Andersen C. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: An opening study. Reprod Biomed Online 2004; 8:635-643.
15. Kolibianakis EM, Kalogeropoulou L, Griesinger G, Papanikolaou EG, Papadimas J, Bontis J, Tarlatzis BC. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth?. A systematic review and meta-analysis. Hum Reprod Update 2007; 13:445-452.
16. Levi-Setti PE, Cavagna M, Bulletti C. Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: Comparison of r-FSH alone and in combination with r-LH. Eur J Obstet Gynecol Reprod Biol 2006;126:212-216.
17. Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L, Kelly E. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online 2004;8:175-182.
18. Mochtar MH, Van der Veen F, Ziech M, van Wely M. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 2007; 2:CD005070.
19. Musters AM, van Wely M, Mastenbroek S, Kaaijk EM, Repping S, van der Veen F, Mochtar MH. The effect of recombinant LH on embryo quality: A randomized controlled trial in women with poor ovarian reserve. Hum Reprod 2012;27:244-250.
20. Nyboe Andersen A, Humaidan P, Fried G, Hausken J, Antila L, Bangsbøll S, Rasmussen PE, Lindenberg S, Bredkjaer HE, Meinertz H; Nordic LH Study Group. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. Amulticentre, prospective, randomized, controlled trial. Hum Reprod 2008;23:427-434.
21. Sauer MV, Thornton MH II, Schoolcraft W, Frishman GN. Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction. Reprod Biomed Online 2004; 9:487-493.
22. Spencer JB, Browne AS, Copland SD, Session DR. Discontinuation or rLH two days before hCG may increase the number of oocytes retrieved in IVF. Reprod Biol Endocrinol 2010;8:29.
23. Thuesen LL, Loft A, Egeberg AN, Smitz J, Petersen JH, Andersen AN. A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization. Hum Reprod 2012;27:3074-3084.